EMB and prostate cancer: Almost the same patterns of molecular signaling were also observed in both the LNCaP prostate cancer cell line in a transient expression system (Figure S5A, Supplementary Materials) and the DU145 subline with stable expression of exogenous embigin (Figure 7B).